New hypothesis for insulin resistance in hypertension due to receptor cleavage

References

• Luft FC, Mervaala E, Muller DN et al. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension33(1 Pt 2), 212–218 (1999).
   PubMed Web of Science ®Google Scholar
• Suematsu M, Suzuki H, Delano FA, Schmid-Schönbein GW. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation9(4), 259–276 (2002).
   PubMed Web of Science ®Google Scholar
• Bikhazi AB, Azar ST, Birbari AE et al. Characterization of insulin-resistance: role of receptor alteration in insulin-dependent diabetes mellitus, essential hypertension and cardiac hypertrophy. Eur. J. Pharm. Sci.11(4), 299–306 (2000).
   PubMedGoogle Scholar
• Bursztyn M, Ben-Ishay D, Gutman A. Insulin resistance in spontaneously hypertensive rats but not in deoxycorticosterone-salt or renal vascular hypertension. J. Hypertens.10(2), 137–142 (1992).
   PubMedGoogle Scholar
• Hulman S, Falkner B, Freyvogel N. Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinemic clamp study. Metabolism42(1), 14–18 (1993).
   PubMed Web of Science ®Google Scholar
• Potenza MA, Marasciulo FL, Chieppa DM et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am. J. Physiol. Heart Circ. Physiol.289(2), H813–822 (2005).
   PubMed Web of Science ®Google Scholar
• Sechi LA, Griffin CA, Giacchetti G et al. Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension27(4), 955–961 (1996).
   PubMed Web of Science ®Google Scholar
• Watanabe T, Iizuka Y, Liang YQ et al. Evaluation of insulin resistance linkage to rat chromosome 4 in SHR of a Japanese colony. Biochem. Biophys. Res. Commun.329(3), 879–887 (2005).
   PubMedGoogle Scholar
• Mondon CE, Reaven GM, Azhar S, Lee CM, Rabkin R. Abnormal insulin metabolism by specific organs from rats with spontaneous hypertension. Am. J. Physiol., 257, E491–E498 (1989).
   PubMed Web of Science ®Google Scholar
• Tran ED, Schmid-Schönbein GW. An in-vivo analysis of capillary stasis and endothelial apoptosis in a model of hypertension. Microcirculation14(8), 793–804 (2007).
   PubMed Web of Science ®Google Scholar
• Lim HH, DeLano FA, Schmid-Schönbein GW. Life and death cell labeling in the microcirculation of the spontaneously hypertensive rat. J. Vasc. Res.38(3), 228–236 (2001).
   PubMedGoogle Scholar
• Arndt H, Smith CW, Granger DN. Leukocyte-endothelial cell adhesion in spontaneously hypertensive and normotensive rats. Hypertension21, 667–673 (1993).
   PubMedGoogle Scholar
• Suematsu M, Suzuki H, Tamatani T et al. Impairment of selectin-mediated leukocyte adhesion to venular endothelium in spontaneously hypertensive rats. J. Clin. Invest.96(4), 2009–2016 (1995).
   PubMedGoogle Scholar
• Schmid-Schönbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension17, 323–330 (1991).
   PubMed Web of Science ®Google Scholar
• Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilatation in arterioles of spontaneously hypertensive rats. Circ. Res.74, 416–421 (1994).
   PubMed Web of Science ®Google Scholar
• Koller A, Huang A. Shear stress-induced dilation is attenuated in skeletal muscle arterioles of hypertensive rats. Hypertension25, 758–763 (1995).
   PubMedGoogle Scholar
• Fukuda S, Yasu T, Kobayashi N, Ikeda N, Schmid-Schönbein GW. Contribution of fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hypertensive rat. Circ. Res.95(1), 100–108 (2004).
   PubMedGoogle Scholar
• Nurkiewicz TR, Boegehold MA. High dietary salt alters arteriolar myogenic responsiveness in normotensive and hypertensive rats. Am. J. Physiol.275(6 Pt 2), H2095–H2104 (1998).
   PubMed Web of Science ®Google Scholar
• Kuo TB, Shaw FZ, Lai CJ, Lai CW, Yang CC. Changes in sleep patterns in spontaneously hypertensive rats. Sleep27(3), 406–412 (2004).
   PubMedGoogle Scholar
• Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OB-R. Cell83(7), 1263–1271 (1995).
   PubMed Web of Science ®Google Scholar
• Collier GR, De Silva A, Sanigorski A, Walder K, Yamamoto A, Zimmet P. Development of obesity and insulin resistance in the Israeli sand rat (Psammomys obesus). Does leptin play a role?. Ann. NY Acad. Sci.827, 50–63 (1997).
   PubMedGoogle Scholar
• Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia14(3), 141–148 (1978).
   PubMed Web of Science ®Google Scholar
• Rubanyi GM. Vascular effects of oxygen-derived free radicals. Free Radic. Biol. Med.4(2), 107–120 (1988).
   PubMed Web of Science ®Google Scholar
• Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension44(4), 381–386 (2004).
   PubMed Web of Science ®Google Scholar
• DeLano FA, Balete R, Schmid-Schönbein GW. Control of oxidative stress in microcirculation of spontaneously hypertensive rats. Am J. Physiol. Heart Circ. Physiol.288(2), H805–H812 (2005).
   Google Scholar
• Swei A, Lacy F, Delano FA, Parks DA, Schmid-Schönbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation6(3), 179–187 (1999).
   PubMed Web of Science ®Google Scholar
• Sedeek MH, Llinas MT, Drummond H et al. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension42(4), 806–810 (2003).
   PubMedGoogle Scholar
• Kobayashi N, DeLano FA, Schmid-Schönbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler. Thromb. Vasc. Biol.25(10), 2114–2121 (2005).
   PubMed Web of Science ®Google Scholar
• Makino A, Skelton MM, Zou AP, Cowley AW Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension42(1), 25–30 (2003).
   PubMed Web of Science ®Google Scholar
• Newaz MA, Yousefipour Z, Nawal NN. Modulation of nitric oxide synthase activity in brain, liver, and blood vessels of spontaneously hypertensive rats by ascorbic acid: protection from free radical injury. Clin. Exp. Hypertens.27(6), 497–508 (2005).
   PubMed Web of Science ®Google Scholar
• Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension32(1), 59–64 (1998).
   PubMed Web of Science ®Google Scholar
• Suzuki H, Swei A, Zweifach BW, Schmid-Schönbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension25, 1083–1089 (1995).
   PubMed Web of Science ®Google Scholar
• Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension30(6), 1628–1633 (1997).
   PubMed Web of Science ®Google Scholar
• Lacy F, O’Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J. Hypertens.16(3), 291–303 (1998).
   PubMed Web of Science ®Google Scholar
• Ito H, Torii M, Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin. Exp. Hypertens.17(5), 803–816 (1995).
   PubMed Web of Science ®Google Scholar
• Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J. Hypertens.19(4), 741–748 (2001).
   PubMed Web of Science ®Google Scholar
• Suzuki H, DeLano FA, Parks DA et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl Acad. Sci. USA95, 4754–4759 (1998).
   PubMed Web of Science ®Google Scholar
• Griendling KK, Harrison DG. Dual role of reactive oxygen species in vascular growth. Circ. Res.85(6), 562–563 (1999).
   PubMed Web of Science ®Google Scholar
• Bauersachs J, Bouloumié A, Mülsch A, Wiemer G, Fleming I, Busse R. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc. Res.37(3), 772–779 (1998).
   PubMed Web of Science ®Google Scholar
• Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation100(3), 292–298 (1999).
   PubMed Web of Science ®Google Scholar
• Lenda DM, Sauls BA, Boegehold MA. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J. Physiol. Heart Circ. Physiol.279(1), H7–H14 (2000).
   PubMed Web of Science ®Google Scholar
• Heitzer T, Wenzel U, Hink U et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int.55(1), 252–260 (1999).
   PubMed Web of Science ®Google Scholar
• Welch WJ, Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int.59(4), 1257–1263 (2001).
   PubMed Web of Science ®Google Scholar
• DeLano FA, Schmid-Schönbein GW. Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat. Hypertension52(2), 415–423 (2008).
   PubMed Web of Science ®Google Scholar
• Rosario HS, Waldo SW, Becker SA, Schmid-Schönbein GW. Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am. J. Pathol.164(5), 1707–1716 (2004).
   PubMed Web of Science ®Google Scholar
• Sobey CG, Moffatt JD, Cocks TM. Evidence for selective effects of chronic hypertension on cerebral artery vasodilation to protease-activated receptor-2 activation. Stroke30(9), 1933–1940 (1999).
   PubMedGoogle Scholar
• Gao X, Belmadani S, Picchi A et al. Tumor necrosis factor-α induces endothelial dysfunction in Lepr(db) mice. Circulation115(2), 245–254 (2007).
   PubMed Web of Science ®Google Scholar
• El Aoufi S, Gendre P, Sennoune SR, Rigoard P, Maixent JM, Griene L. A high calorie diet induces type 2 diabetes in the desert sand rat (Psammomys obesus). Cell. Mol. Biol. (Noisy-le-grand)53(Suppl.), OL943–OL953 (2007).
   PubMed Web of Science ®Google Scholar
• Chavey C, Mari B, Monthouel MN et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J. Biol. Chem.278(14), 11888–11896 (2003).
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Oh KB, Saito M, Nemoto Y, Matsuoka H. Evaluation of 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose, a new fluorescent derivative of glucose, for viability assessment of yeast Candida albicans. Appl. Microbiol. Biotechnol.46(4), 400–404 (1996).
   PubMedGoogle Scholar
• Park Y, Capobianco S, Gao X, Falck JR, Dellsperger KC, Zhang C. Role of EDHF in Type 2 diabetes-induced endothelial dysfunction. Am J. Physiol. Heart Circ. Physiol.295(5), H1982–H1988 (2008).
   PubMed Web of Science ®Google Scholar
• Tran ED, DeLano FA, Schmid-Schönbein GW. Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J. Vasc. Res. (2009) (In press).
   Google Scholar
• Peterson JT, Hallak H, Johnson L et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation103(18), 2303–2309 (2001).
   PubMed Web of Science ®Google Scholar
• Liebetrau M, Burggraf D, Wunderlich N, Jager G, Linz W, Hamann GF. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats. Neurosci. Lett.376(3), 205–209 (2005).
   PubMedGoogle Scholar
• Nunez E, Hosoya K, Susic D, Frohlich ED. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR. Hypertension29(1 Pt 2), 519–524 (1997).
   PubMed Web of Science ®Google Scholar
• Norman JA, Lehmann M, Goodman FR, Barclay BW, Zimmerman MB. Central and peripheral inhibition of angiotensin converting enzyme (ACE) in the SHR: correlation with the antihypertensive activity of ACE inhibitors. Clin. Exp. Hypertens. A9(2–3), 461–468 (1987).
   PubMed Web of Science ®Google Scholar
• Lan L, Di Nicolantonio R, Bramich C, Morgan TO. Brief treatment of SHR with an ace inhibitor fails to cause long-term normotension but markedly increases mortality. Clin. Exp. Pharmacol. Physiol.22(Suppl. 1), S345–346 (1995).
   PubMedGoogle Scholar
• Rizzoni D, Rodella L, Porteri E et al. Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats. Clin. Exp. Hypertens.25(7), 427–441 (2003).
   PubMed Web of Science ®Google Scholar
• Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab.27(4), 697–709 (2007).
   PubMedGoogle Scholar
• Rosenberg GA, Cunningham LA, Wallace J et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res.893(1–2), 104–112 (2001).
   PubMed Web of Science ®Google Scholar
• Aoki T, Sumii T, Mori T, Wang X, Lo EH. Blood–brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke33(11), 2711–2717 (2002).
   PubMed Web of Science ®Google Scholar
• Richer C, Fornes P, Vacher E, Bruneval P, Giudicelli JF. Trandolapril’s protective effects in stroke-prone spontaneously hypertensive rats persist long after treatment withdrawal. Am. J. Cardiol.73(10), 26C–35C (1994).
   PubMed Web of Science ®Google Scholar
• Reinhardt D, Sigusch HH, Hensse J, Tyagi SC, Korfer R, Figulla HR. Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart88(5), 525–530 (2002).
   PubMedGoogle Scholar
• Seeland U, Kouchi I, Zolk O, Itter G, Linz W, Bohm M. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. J. Mol. Cell. Cardiol.34(2), 151–163 (2002).
   PubMedGoogle Scholar
• Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res.90(3), 251–262 (2002).
   PubMed Web of Science ®Google Scholar
• Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res.90(5), 520–530 (2002).
   PubMed Web of Science ®Google Scholar
• Kuzuya M, Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J. Atheroscler. Thromb.10(5), 275–282 (2003).
   PubMedGoogle Scholar
• Soluble insulin receptor ectodomain is elevated in the plasma of patients with diabetes. Diabetes56(8), 2028–2035 (2007).
   PubMedGoogle Scholar
• Wada H, Satoh N, Kitaoka S et al. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis DOI: 10.1016/j.atherosclerosis.2009.07.045 (2009) (Epub ahead of print).
   Google Scholar
• Carlin C, Phillips PD, Brooks-Frederich K, Knowles BB, Cristofalo VJ. Cleavage of the epidermal growth factor receptor by a membrane-bound leupeptin-sensitive protease active in nonionic detergent lysates of senescent but not young human diploid fibroblasts. J. Cell Physiol.160(3), 427–434 (1994).
   PubMedGoogle Scholar
• Kojro E, Fahrenholz F. Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase. J. Biol. Chem.270(12), 6476–6481 (1995).
   PubMed Web of Science ®Google Scholar
• Raucci A, Cugusi S, Antonelli A et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J.22(10), 3716–3727 (2008).
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Piffath CL, Cheng G et al. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIba shedding from platelets in vitro and in vivo. Circ. Res.95(7), 677–683 (2004).
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yamagishi S, Adachi H et al. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with Type 2 diabetes. Microvasc. Res.76(1), 52–56 (2008).
   PubMed Web of Science ®Google Scholar
• Lefkowitz RB, Marciniak JY, Hu C-M, Schmid-Schönbein GW, Heller MJ. An electrophoretic method for the detection of chymotrypsin and trypsin activity directly in whole blood. Electrophoresis (2009) (In press).
   Google Scholar